Perceived Difficulty of Diabetes Treatment in Primary Care: Does it Differ by Patient Ethnicity?

The Diabetes Educator

Volumn 27, Issue 5, 2001, Pages 678-684

  Egede, Leonard E ^a   Miohel, Yvonne ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; EPIDEMIOLOGY; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; MALE; PRIMARY HEALTH CARE; RACE; UNITED STATES;

ADULT; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; MALE; PRIMARY HEALTH CARE; UNITED STATES;

EID: 0035468214     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572170102700508     Document Type: Article

References (30)

1. National Institute of Diabetes and Digestive and Kidney Disorders. Diabetes Statistics. Bethesda, Md: National Institutes of Health; 1999. NIH publication 99-3892. Available at: www.niddk.nih.gov/health/diabetes/pubs/dmstats/dmstats.htm.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329: 977-986.
3. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
4. United Kingdom Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with mefformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
5. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317: 703-713.
6. United Kingdom Prospective Diabetes Study (UKPDS) Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ. 1998;317: 720-726.
7. American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care. 2000;23(suppl 1): S1-S116.
8. Harris MI. Medical care for patients with diabetes. Epidemiologic aspects. Ann Intern Med. 1996;124:117-122.
9. Laine C, Caro JF. Preventing complications in diabetes mellitus: the role of the primary care physician. Med Clin North Am. 1996;80:457-474.
10. Peters AL, Legorreta AP, Ossorio RC, Davidson MB. Quality of outpatient care provided to diabetic patients. A health maintenance organization experience. Diabetes Care. 1996;19:601-606.
11. Streja DA, Rabkin SW. Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med. 1999;159:294-302.
12. Glasgow RE, Boles SM, Calder D, Dreyer L, Bagdade J. Diabetes care practices in primary care: results from two samples and three measurement sets. Diabetes Educ. 1999;25:755-763.
13. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282:1458-1465.
14. Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the diabetes attitude scale. Diabetes Care. 1998;21:1403-1407.
15. Anderson RM, Donnelly MB, Davis WK. Controversial beliefs about diabetes and its care. Diabetes Care. 1992;15: 859-863.
16. Anderson RM, Donnelly MB, Dedrick RF, Gressard CP. The attitudes of nurses, dietitians, and physicians toward diabetes. Diabetes Educ. 1991; 17:261-268.
17. Kenny SJ, Smith PJ, Goldschmid MG, Newman JM, Herman WH. Survey of physician practice behaviors related to diabetes mellitus in the US. Physician adherence to consensus recommendations. Diabetes Care. 1993;16: 1507-1510.
18. National Institutes of Health. Metabolic Control Matters: Nationwide Translation of the Diabetes Control and Complications Trial: Analysis and Recommendations. Bethesda, Md: National Institutes of Health; 1994. NIH publication 94-3773.
19. Anderson RM, Herman WH, Davis JM, Freedman RP, Funnell MM, Neighbors HW. Barriers to improving diabetes care for blacks [editorial]. Diabetes Care. 1991;14:605-609.
20. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care. 1998;21: 1391-1396.
21. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14: 537-546.
22. Freedman TG. “Why don't they come to Pike Street and ask us?” Black American women's health concerns. Soc Sci Med. 1998;47:941-947.
23. Schoenberg NE, Amey CH, Coward RT. Diabetes knowledge and sources of information among African American and white older women. Diabetes Educ. 1998;24: 319-324.
24. Nurss JR, El-Kebbi IM, Gallina DL, et al. Diabetes in urban African Americans: functional health literacy of municipal hospital outpatients with diabetes. Diabetes Educ. 1997;23:563-568.
25. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000; 160:2281-2286.
26. Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the Study of Hypertensive Prescribing Practices (SHyPP). Am J Hypertens. 1999;12:333-340.
27. Smith NL, Psaty BM, Pitt B, Garg R, Gottdiener JS, Heckbert SR. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. Arch Intern Med. 1998;158:1074-1080.
28. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460-2464.
29. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997;2:523-530.
30. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 1997;87: 643-648.